The Hindu·1 min read·medium
Lupin gets U.S FDA nod for Pitolisant tablets
T
The Hindu Bureau
✦AI Summary
Lupin has received U.S. FDA approval for its generic version of Pitolisant tablets, used to treat narcolepsy-related symptoms. The generic drug is confirmed as bioequivalent to the branded medication Wakix.
Drugmaker Lupin on Monday said it has received the final approval from the U.S. Food and Drug Administration (U.S. FDA) for its abbreviated new drug application for Pitolisant Tablets, 4.45 mg and 17.8 mg.
businesshealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in